Adaptive Blood Treatment Systems for Niche Environments

Publication ID: 24-11857711_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Blood Treatment Systems for Niche Environments,” Published Technical Disclosure No. 24-11857711_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857711_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,711.

Summary of the Inventive Concept

The inventive concept adapts blood treatment apparatuses for specific, narrow markets or unique operational environments, ensuring optimal treatment outcomes in high-security needs, disaster relief, extreme weather conditions, and areas with limited power supply or medical resources.

Background and Problem Solved

The original patent relates to a method for setting a control device or a closed-loop control device of a blood treatment apparatus. However, it does not address the challenges of adapting these systems for use in niche environments. The inventive concept solves this problem by introducing specialized variations and niche solutions for blood treatment apparatuses.

Detailed Description of the Inventive Concept

The inventive concept comprises a system for blood treatment in high-security environments, disaster relief scenarios, extreme weather conditions, and areas with limited power supply or medical resources. These systems include a blood treatment apparatus, a dialysis liquid inlet line, a dialysis liquid pump, and a control device configured to adjust the dialysis liquid pump based on a predetermined correction factor. The correction factor ensures a secure, stable, or optimal treatment outcome, depending on the specific environment. The systems can be adapted for use in areas with limited power supply by incorporating power-saving control devices or in areas with limited medical resources by calculating the correction factor based on the availability of resources.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of blood treatment apparatuses for specific, narrow markets or unique operational environments. The inventive step is the introduction of specialized correction factors and control devices that ensure optimal treatment outcomes in these environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of pumps, sensors, or control devices. Variations could include adapting the systems for use in other niche environments, such as remote or rural areas, or integrating the systems with other medical devices.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of blood treatment, dialysis, and disaster relief. The target market includes hospitals, clinics, and medical organizations operating in niche environments.

CPC Classifications

SectionClassGroup
A A61 A61M1/1601
A A61 A61M1/28
A A61 A61M1/34
A A61 A61M60/113
A A61 A61M2205/3334

Field of Art

Medical device engineering, specifically blood treatment apparatus design, focusing on dialysis systems, extracorporeal blood circulation control, and adaptive medical device technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in medical device design, fluid dynamics, control systems, and medical equipment adaptation for variable clinical environments, typically holding a masters or PhD in biomedical engineering with 3-5 years of specialized experience

Obviousness Rationale

A PHOSITA would recognize that the source patent's fundamental blood treatment apparatus design provides a flexible framework that can be readily adapted to different operational contexts by modifying control parameters and system configurations. The PTD's variations represent predictable extensions of the source patent's core technological principles, utilizing standard engineering design approaches to customize medical devices for specific environmental constraints. The disclosed modifications involve routine engineering adaptations that would be obvious to a skilled practitioner familiar with medical device design and control systems.

Obvious Combinations & Variations

Source Patent Element
Control device configured to adjust dialysis liquid pump based on treatment parameters
PTD Variation
Adapting control device for high-security or disaster relief environments with specialized correction factors
Obviousness Reasoning
Predictable variation using known control system modification techniques to address specific operational requirements
Source Patent Element
Predetermined correction factor between 10% and 30% for treatment parameters
PTD Variation
Calculating correction factor based on resource availability in limited medical environments
Obviousness Reasoning
Routine engineering design choice extending existing parameter adjustment methodology to constrained resource scenarios
Source Patent Element
Blood treatment apparatus with extracorporeal blood circuit and dialysis liquid pump
PTD Variation
Integrating power-saving control mechanisms for environments with limited electrical infrastructure
Obviousness Reasoning
Known technique of implementing energy-efficient design strategies in medical device engineering
Source Patent Element
Method for setting control device based on treatment targets
PTD Variation
Customizing treatment target determination for extreme environmental conditions
Obviousness Reasoning
Obvious application of existing control methodology to novel operational contexts using standard engineering problem-solving approaches
35 U.S.C. § 103 Summary: Based on US Patent 11857711's comprehensive disclosure of blood treatment apparatus control methodologies, the present published technical disclosure demonstrates that the claimed variations represent obvious modifications to the prior art, employing standard engineering design techniques to adapt medical devices for specific environmental constraints. A person having ordinary skill in the art would find the disclosed system configurations and method adaptations to be straightforward extensions of the existing technological framework, lacking any non-obvious inventive step.

Original Patent Information

Patent NumberUS 11,857,711
TitleMethod for setting a control device or a closed-loop control device of a blood treatment apparatus, and devices
Assignee(s)Fresenius Medical Care Deutschland GmbH